Literature DB >> 33603581

Osmolality of Commonly Used Oral Medications in the Neonatal Intensive Care Unit.

Dhara D Shah, Andriy Kuzmov, Dana Clausen, Anita Siu, Christine A Robinson, Katelin Kimler, Rachel Meyers, Pooja Shah.   

Abstract

OBJECTIVE: The administration of hyperosmolar oral products in neonates has been associated with gastrointestinal complications. The American Academy of Pediatrics recommends a maximum osmolality of 450 mOsm/kg for formulas and enteral nutrition for term infants, and recent studies reported intolerance to enteral nutrition with osmolality above 500 mOsm/kg in low birthweight infants. The osmolality of medications administered to neonates is often not available in the literature or from manufacturers. The purpose of this study was to determine the osmolality of oral medications commonly administered to neonates in the NICU.
METHODS: Fifty-two oral medications were chosen for this study, including solutions, suspensions, syrups, elixirs, and intravenous solutions administered orally. The osmolality of each medication was measured in triplicate by using freezing point depression.
RESULTS: Thirty-seven of the 43 medications with measurable values (86.1%) had an osmolality greater than 500 mOsm/kg, and 6 medications (14%) had an osmolality less than 500 mOsm/kg. Nine medications did not result in a value.
CONCLUSIONS: Our study provides osmolality data on oral medications commonly used in neonates with most oral medications having an osmolality greater than 500 mOsm/kg. Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: mhelms@pediatricpharmacy.org 2021.

Entities:  

Keywords:  neonates; oral medications; osmolality

Year:  2021        PMID: 33603581      PMCID: PMC7887878          DOI: 10.5863/1551-6776-26.2.172

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  18 in total

1.  Stability of oral suspensions of ursodiol made from tablets.

Authors:  Cary E Johnson; Darcie D Streetman
Journal:  Am J Health Syst Pharm       Date:  2002-02-15       Impact factor: 2.637

Review 2.  Milk osmolality: does it matter?

Authors:  Freya Pearson; Mark J Johnson; Alison A Leaf
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2011-09-19       Impact factor: 5.747

3.  [Osmolality of oral liquid dosage forms to be administered to newborns in a hospital].

Authors:  A Fernández Polo; M J Cabañas Poy; S Clemente Bautista; M Oliveras Arenas; F Castillo Salinas; E Hidalgo Albert
Journal:  Farm Hosp       Date:  2007 Sep-Oct

4.  Osmolality, pH, and compatibility of selected oral liquid medications with an enteral nutrition product.

Authors:  Mark Klang; Veronica McLymont; Nicole Ng
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-01-17       Impact factor: 4.016

Review 5.  The dynamic gastric environment and its impact on drug and formulation behaviour.

Authors:  Jens Van Den Abeele; Jari Rubbens; Joachim Brouwers; Patrick Augustijns
Journal:  Eur J Pharm Sci       Date:  2016-09-03       Impact factor: 4.384

6.  Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.

Authors:  L V Allen; M A Erickson
Journal:  Am J Health Syst Pharm       Date:  1996-09-01       Impact factor: 2.637

Review 7.  Necrotizing enterocolitis.

Authors:  Josef Neu; W Allan Walker
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

8.  Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids.

Authors:  L V Allen; M A Erickson
Journal:  Am J Health Syst Pharm       Date:  1998-09-15       Impact factor: 2.637

Review 9.  Evolving understanding of neonatal necrotizing enterocolitis.

Authors:  Mubina A Isani; Patrick T Delaplain; Anatoly Grishin; Henri R Ford
Journal:  Curr Opin Pediatr       Date:  2018-06       Impact factor: 2.856

10.  Milk feed osmolality and adverse events in newborn infants and animals: a systematic review.

Authors:  Zoë-Marie Ellis; Hui Shan Grace Tan; Nicolas D Embleton; Per Torp Sangild; Ruurd M van Elburg
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2018-12-06       Impact factor: 5.747

View more
  1 in total

1.  Beyond-Use Dates Assignment for Pharmaceutical Preparations: Example of Low-Dose Amiodarone Capsules.

Authors:  Damien Brun; Christophe Curti; Edouard Lamy; Christophe Jean; Pierre Bertault-Peres; Julie Broggi; Guillaume Tintori; Patrice Vanelle
Journal:  J Pharm Technol       Date:  2021-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.